# An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma

> **NCT05759325** · — · NOT_YET_RECRUITING · sponsor: **Guangzhou Institute of Respiratory Disease** · enrollment: 100 (estimated)

## Conditions studied

- Squamous Cell Carcinoma of Esophagus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05759325
- **Lead sponsor:** Guangzhou Institute of Respiratory Disease
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-03
- **Primary completion:** 2026-03
- **Final completion:** 2026-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05759325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05759325, "An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05759325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*